Table 3.
Clinical outcomes of all patients receiving high-flow nasal cannula therapy those with and without epistaxis
| Variable | Total n = 70 | Epistaxis n = 7 | No epistaxis n = 63 | p value |
|---|---|---|---|---|
| Need of mechanical ventilation after HFNC therapy | 33 (47.1) | 3 (42.9) | 30 (47.6) | 1 |
| ICU mortality | 30 (42.9) | 3 (42.9) | 27 (42.9) | 1 |
| ICU length-of-stay (days) | 12 [7 - 22] | 21 [6 - 22] | 12 [7 - 20.5] | 0.92 |
| In-hospital mortality | 40 (57.1) | 4 (57.1) | 36 (57.1) | 1 |
| In-hospital length-of-stay (days) | 28.5 [16 - 48.5] | 28 [15 - 33] | 29 [16.5 - 49.5] | 0.41 |
HFNC - high-flow nasal cannula; ICU - intensive care unit. Results expressed as n (%) or median [interquartile range].